EspB and HtpG interact with the type III-A CRISPR/Cas system of Mycobacterium tuberculosis

Front Mol Biosci. 2023 Nov 27:10:1261613. doi: 10.3389/fmolb.2023.1261613. eCollection 2023.

Abstract

Introduction: Mycobacterium tuberculosis (MTB) has a type III-A clustered regularly interspaced short palindromic repeat/CRISPR-associated protein (CRISPR/Cas) system consisting of a Csm1-5 and CRISPR RNA (crRNA) complex involved in the defense against invading nucleic acids. However, CRISPR/Cas system in the MTB still is clearly unknown and needs to be further explored. Methods: In our work, two non-Cas system proteins EspB and HtpG protein were found and identified by LC-MS/MS. The effect of EspB and HtpG on Type III-A CRISPR/Cas System of M. tuberculosis was examined by using Plasmid interference assay and Co-immunoprecipitation analyses. We explored that EspB could interact with the crRNA RNP complex, but HtpG could inhibit the accumulation of the MTB Csm proteins and defense the mechanism of CRISPR/Cas system. Results: The proteins ESAT-6 secretion system-1(Esx-1) secreted protein B (EspB) and high-temperature protein G (HtpG), which were not previously associated with CRISPR/Cas systems, are involved in mycobacterial CRISPR/Cas systems with distinct functions. Conclusion: EspB is a novel crRNA-binding protein that interacts directly with the MTB crRNP complex. Meanwhile, HtpG influences the accumulation of MTB Csm proteins and EspB and interferes with the defense mechanism of the crRNP complex against foreign DNA in vivo. Thereby, our study not only leads to developing more precise clinical diagnostic tool to quickly detect for MTB infection, but also knows these proteins merits for TB biomarkers/vaccine candidates.

Keywords: CRISPR/Cas system; Csm; EspB; HtpG; Mycobacterium tuberculosis.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant Number XDB29020000 to LB); The “Dengfeng Plan” High-level Hospital Construction Opening Project of Foshan Fourth People’s Hospital (Grant Numbers FSSYKF-2020007 to LB and FSSYKF-2020014 to YW); The National Natural Science Foundation of China (Grant Number 31770148 to HoZ); The Capital Medical Development Special Foundation (Grant Number 2020-2-1042 to YL); The Capital Health Research and Department of Special (Grant Number 2022-1G-3012 to CL).